Cumulative Serum Endothelin-1 and Endothelin-3 Level Predicts 1-year Adverse Cardiac Events after ST-Elevation Acute Myocardial Infarction
International Journal of Angiology · 01.03.2026 · 35 (01) · 043-049
DOI: 10.1055/a-2572-0833 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Angiology, erschienen am 01.03.2026. Verfasst von Astrid Karina Putri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogya…. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Dana Masyarakat FK-KMK Universitas Gadjah Mada, Yogyakarta, Indonesia, Academic Excellence Improvement Program Universitas Gadjah Mada.
Abstract (Originalsprache)
Endothelin-1 (ET-1) and endothelin-3 (ET-3) released in circulation during acute myocardial infarction (AMI) contribute to vasoconstriction, which elevates the severity of the myocardial infarction. This study aims to investigate the role of cumulative ET-1 and ET-3 levels on the major adverse cardiac events (MACE) 1 year after AMI hospitalization. This retrospective cohort study included patients with ST-elevation acute myocardial infarction (STEMI). Baseline data were collected, including sociodemographic characteristics, clinical data, and serum ET-1 and ET-3 levels, measured with ELISA assay. Follow-up was performed 1 year after hospital discharge to identify MACE. A multivariate logistic regression was performed to describe predictors of 1-year MACE. A total of 81 subjects were enrolled and followed up. Subjects were divided into two groups based on their cumulative ET-1 and ET-3 levels, using a rounded cut-off point of 17.0 ng/mL, produced by the ROC curve for MACE. At 1 year MACE occurred in 24 (29.3%) subjects. A multivariate analysis demonstrated that a cumulative ET-1 and ET-3 level >17.0 ng/mL was independently associated with 1-year MACE (aOR = 5.34, 95% CI: 1.36–21.07, p = 0.017). A higher cumulative serum ET-1 and ET-3 level at admission predicts MACE in 1 year of follow-up after STEMI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia.
- Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia.
ORCID-Profile: Anggoro Budi Hartopo
Förderung
- Dana Masyarakat FK-KMK Universitas Gadjah Mada, Yogyakarta, Indonesia
- Academic Excellence Improvement Program Universitas Gadjah Mada
Zitieren
APA
Putri, A. K., Hartopo, A. B., Puspitawati, I., & Setianto, B. Y. (2026). Cumulative Serum Endothelin-1 and Endothelin-3 Level Predicts 1-year Adverse Cardiac Events after ST-Elevation Acute Myocardial Infarction. International Journal of Angiology, 35(01), 043-049. https://doi.org/10.1055/a-2572-0833
Vancouver
Putri AK, Hartopo AB, Puspitawati I, Setianto BY. Cumulative Serum Endothelin-1 and Endothelin-3 Level Predicts 1-year Adverse Cardiac Events after ST-Elevation Acute Myocardial Infarction. International Journal of Angiology. 2026;35(01):043-049. doi:10.1055/a-2572-0833
BibTeX
@article{Putri2026,
author = {Putri, Astrid Karina and Hartopo, Anggoro Budi and Puspitawati, Ira and Setianto, Budi Yuli},
title = {Cumulative Serum Endothelin-1 and Endothelin-3 Level Predicts 1-year Adverse Cardiac Events after ST-Elevation Acute Myocardial Infarction},
journal = {International Journal of Angiology},
year = {2026},
volume = {35},
number = {01},
pages = {043--049},
doi = {10.1055/a-2572-0833}
}
EUVIMED